{"transactions":[{"id":2368355,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":129870,"kind":"person","name":"Greenhalgh Ellis Skott","position":1,"cik":"0001790671","reported_name":"Greenhalgh Ellis Skott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-02-28T21:24:06.000Z","date":"2022-02-24","kind":"tax_withholding","acquired":false,"shares":973,"price":11.98,"value":11656.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":27826,"source":{"system":"sec-edgar","filing":"0001062993-22-005910","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299322005910/form4.xml","form_type":"4"}},{"id":2371463,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":129870,"kind":"person","name":"Greenhalgh Ellis Skott","position":1,"cik":"0001790671","reported_name":"Greenhalgh Ellis Skott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-25T22:10:23.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":6675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":6675,"derivative":{"exercise_price":11.75,"expiration_date":"2032-02-23","underlying":"Common Stock","underlying_shares":6675},"source":{"system":"sec-edgar","filing":"0001062993-22-005779","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299322005779/form4.xml","form_type":"4"}},{"id":2371462,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":129870,"kind":"person","name":"Greenhalgh Ellis Skott","position":1,"cik":"0001790671","reported_name":"Greenhalgh Ellis Skott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-02-25T22:10:23.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates."}],"balance_after":28799,"source":{"system":"sec-edgar","filing":"0001062993-22-005779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299322005779/form4.xml","form_type":"4"}},{"id":2760449,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":129870,"kind":"person","name":"Greenhalgh Ellis Skott","position":1,"cik":"0001790671","reported_name":"Greenhalgh Ellis Skott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-04-02T18:43:01.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":2789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in four equal annual installments beginning on March 31, 2022, subject to the Reporting Person's continuous service with the Issuer."}],"balance_after":24899,"source":{"system":"sec-edgar","filing":"0001192482-21-000299","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248221000299/edgar.xml","form_type":"4"}},{"id":2829029,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":129870,"kind":"person","name":"Greenhalgh Ellis Skott","position":1,"cik":"0001790671","reported_name":"Greenhalgh Ellis Skott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-26T22:29:09.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on February 24, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer."}],"balance_after":21000,"derivative":{"exercise_price":16.99,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001192482-21-000191","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248221000191/edgar.xml","form_type":"4"}},{"id":2829028,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":129870,"kind":"person","name":"Greenhalgh Ellis Skott","position":1,"cik":"0001790671","reported_name":"Greenhalgh Ellis Skott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-02-26T22:29:09.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":11600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in four equal annual installments beginning on February 24, 2022, subject to the Reporting Person's continuous service with the Issuer."}],"balance_after":22110,"source":{"system":"sec-edgar","filing":"0001192482-21-000191","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248221000191/edgar.xml","form_type":"4"}},{"id":3372487,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":129870,"kind":"person","name":"Greenhalgh Ellis Skott","position":1,"cik":"0001790671","reported_name":"Greenhalgh Ellis Skott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:49:30.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":1976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":1976,"derivative":{"exercise_price":28.65,"exercise_date":"2019-11-13","expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":80},"source":{"system":"sec-edgar","filing":"0001192482-19-000422","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000422/edgar.xml","form_type":"4"}},{"id":3372486,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":129870,"kind":"person","name":"Greenhalgh Ellis Skott","position":1,"cik":"0001790671","reported_name":"Greenhalgh Ellis Skott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:49:30.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":1976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":1.16,"exercise_date":"2017-01-18","expiration_date":"2027-01-18","underlying":"Series B Preferred Stock","underlying_shares":1976},"source":{"system":"sec-edgar","filing":"0001192482-19-000422","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000422/edgar.xml","form_type":"4"}},{"id":3372485,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":129870,"kind":"person","name":"Greenhalgh Ellis Skott","position":1,"cik":"0001790671","reported_name":"Greenhalgh Ellis Skott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Series B Preferred Stock","published_at":"2019-11-14T01:49:30.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":120699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4887},"source":{"system":"sec-edgar","filing":"0001192482-19-000422","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000422/edgar.xml","form_type":"4"}},{"id":3372484,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":129870,"kind":"person","name":"Greenhalgh Ellis Skott","position":1,"cik":"0001790671","reported_name":"Greenhalgh Ellis Skott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Series A Preferred Stock","published_at":"2019-11-14T01:49:30.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2025},"source":{"system":"sec-edgar","filing":"0001192482-19-000422","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000422/edgar.xml","form_type":"4"}},{"id":3372483,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":129870,"kind":"person","name":"Greenhalgh Ellis Skott","position":1,"cik":"0001790671","reported_name":"Greenhalgh Ellis Skott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2019-11-14T01:49:30.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":4887,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":10510,"source":{"system":"sec-edgar","filing":"0001192482-19-000422","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000422/edgar.xml","form_type":"4"}},{"id":3372482,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":129870,"kind":"person","name":"Greenhalgh Ellis Skott","position":1,"cik":"0001790671","reported_name":"Greenhalgh Ellis Skott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2019-11-14T01:49:30.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":2025,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 5,623 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a)."}],"balance_after":5623,"source":{"system":"sec-edgar","filing":"0001192482-19-000422","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000422/edgar.xml","form_type":"4"}}]}